DexCom: Q1'22 Earnings Strong Enough To Maintain Valuation But Not To Increase It [Seeking Alpha]
DexCom, Inc. (DXCM)
Last dexcom, inc. earnings: 4/28 04:03 pm
Check Earnings Report
US:NASDAQ Investor Relations:
dexcom.com/investors
Company Research
Source: Seeking Alpha
guvendemir/E+ via Getty ImagesInvestment ThesisDexCom (NASDAQ:DXCMThe integrated continuous glucosemonitoring ("iCGM") device manufacturer's share price is down 3% over the past year, although over a 5-year period it is +436%, which is not untypical for a company that has experienced a period of supercharged growth - its market cap now stands at $40bn - but is now dealing with more demanding expectations from analysts, the market, and its shareholders.Dexcom has seen its revenues grow from $100m in 2012, to $2.5bn in FY21, as the company has emerged as a top 3 iCGM manufacturer and distributor, alongside Abbott (ABTMDTUnlike Abbott - market cap of $200bn - and Medtronic - market cap of $140bn - DexCom's G6 device is its only commercial product. Whilst its rivals are giants in the field of medical devices, DexCom's fate rests solely on its ability to compete successfully for market share in automated monitoring of diabetics' blood sugar levels, and automated delivery of insulin as an w
Show less
Read more
Impact Snapshot
Event Time:
DXCM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DXCM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DXCM alerts
High impacting DexCom, Inc. news events
Weekly update
A roundup of the hottest topics
DXCM
News
- Insulet Reports First Quarter 2024 Revenue Increase of 23% Year-Over-Year [Yahoo! Finance]Yahoo! Finance
- Electronic Skin Patch Market worth $27.0 billion by 2029 - Exclusive Report by MarketsandMarkets™ [Yahoo! Finance]Yahoo! Finance
- DexCom, Inc. (NASDAQ: DXCM) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Market Analysis Forecasts Substantial Growth for Global Artificial Pancreas Device Systems - Projections to 2032 - Technological Innovations and Regulatory Support [Yahoo! Finance]Yahoo! Finance
- Can DexCom, Inc.'s (NASDAQ:DXCM) ROE Continue To Surpass The Industry Average? [Yahoo! Finance]Yahoo! Finance
DXCM
Earnings
- 4/25/24 - Beat
DXCM
Sec Filings
- 5/2/24 - Form 4
- 4/30/24 - Form 144
- 4/25/24 - Form 10-Q
- DXCM's page on the SEC website